This inventor holds 1 USPTO granted patent. Top assignee: National Institute of Biological Sciences, Beijing. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Zhongmin Zhou
Introduction
Zhongmin Zhou is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biomedical research, particularly in the development of therapies for viral infections and other health conditions. His work is characterized by a strong focus on innovative solutions that address pressing medical challenges.
Latest Patents
Zhongmin Zhou holds a patent for NTCP inhibitors. This invention provides cyclosporin A analogues that are NTCP inhibitors and are useful for treating HBV and/or HDV infections, hepatoprotection, and amelioration of hypercholesterolemia and diabetes, as well as inhibiting cancer. This patent highlights his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Zhongmin Zhou is affiliated with the National Institute of Biological Sciences in Beijing. His role at this esteemed institution allows him to engage in cutting-edge research and collaborate with other leading scientists in the field. His work has garnered attention for its potential impact on public health.
Collaborations
Zhongmin Zhou has worked alongside notable colleagues such as Zhiyuan Zhang and Wenhui Li. These collaborations have further enriched his research and contributed to the advancement of innovative solutions in the biomedical sector.
Conclusion
Zhongmin Zhou's contributions to the field of biomedical research, particularly through his patent on NTCP inhibitors, demonstrate his dedication to addressing critical health issues. His work continues to inspire advancements in medical science and offers hope for improved treatments for various diseases.